800401-64-3

Usage

Uses

Used in Pharmaceutical Research:
1H-PYRROLO[3,2-C]PYRIDINE-2-CARBOXYLIC ACID ETHYL ESTER is used as a research compound for its potential biological activity, which may contribute to the discovery and development of new pharmaceutical agents.
Used in Drug Development:
In the pharmaceutical industry, 1H-PYRROLO[3,2-C]PYRIDINE-2-CARBOXYLIC ACID ETHYL ESTER is utilized as a precursor or intermediate in the synthesis of novel drugs, leveraging its structural properties to create molecules with therapeutic potential.

InChI:InChI=1/C10H10N2O2/c1-2-14-10(13)9-5-7-6-11-4-3-8(7)12-9/h3-6,12H,2H2,1H3

Upstream product

• 95-92-1 oxalic acid diethyl ester 
• 1990-90-5 4-amino-3-methylpyridine 
• 180253-65-0 (3-methylpyridin-4-yl)carbamic acid tert-butyl ester 

Downstream Products

• 800401-65-4 1H-pyrrolo [3,2-c] pyridine-2-carboxylic acid 

Relevant academic research and scientific papers

Asymmetric Hydrogenation of Azaindoles: Chemo- and Enantioselective Reduction of Fused Aromatic Ring Systems Consisting of Two Heteroarenes

High enantioselectivity was achieved for the hydrogenation of azaindoles by using the chiral catalyst, which was prepared from [Ru(η3-methallyl)2(cod)] and a trans-chelating bis(phosphine) ligand (PhTRAP). The dearomative reaction exclusively occurred on the five-membered ring, thus giving the corresponding azaindolines with up to 97:3 enantiomer ratio.

PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDE INHIBITORS OF GLYCOGEN PHOSHORYLASE

Compounds represented by Formula (I): or pharmaceutically acceptable salts thereof, are inhibitors of glycogen phosphorylase and are useful in the prophylactic or therapeutic treatment of diabetes, hyperglycemia, hypercholesterolemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis or tissue ischemia e.g. myocardial ischemia, and as cardioprotectants.